Yu Miura

CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy

Hiroshi Kagamu, Shigehisa Kitano, Ou Yamaguchi et al. · Cancer Immunology Research · 2019 · 255 citations

Anti-pd-1 Therapy, Pd-1 Blockade, T-regulatory Cell +27

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

Ayako Shiono, Kyoichi Kaira, Atsuto Mouri et al. · Thoracic Cancer · 2019 · 76 citations · Full text

Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer

Kosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi et al. · Journal of Clinical Medicine · 2020 · 58 citations · Full text

Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto et al. · Thoracic Cancer · 2019 · 51 citations · Full text

Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer

Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi et al. · Cancer Chemotherapy and Pharmacology · 2019 · 50 citations

Clinical Difference, Medicine, Cancer Management +8